Gynecological malignancy organoids: A game changer for personalized medicine
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · 2025
DOI: 10.1016/j.bbcan.2025.189405 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2025. Verfasst von Ziyang Ding und 4 weiteren Autor:innen. Beteiligte Einrichtung: Obstetrics & Gynecology Hospital of Fudan University, Shanghai Key Lab of Reproduction and Development, Shanghai Key Lab of Female Reproductive Endoc…. Hauptthemen laut MEDLINE: Organoids, Precision Medicine, Genital Neoplasms, Female. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 118 Literaturangaben.
Abstract (Originalsprache)
Recently, the incidence of gynecological malignancies has increased annually, posing a serious threat to women's health. Historically, the emergence and progression of gynecological cancers have primarily been studied using cell lines and animal models. However, these models often fail to accurately reflect tumor characteristics because genetic mutations frequently occur during long-term cultivation. Also, the complex tumor microenvironment is difficult to replicate. Consequently, these models have limitations in translating research findings into clinical applications. Organoids successfully retain key characteristics of primary tumors, including histological structure, genomic landscape, expression profiles, and intratumor heterogeneity. They provide new solutions to these challenges and have been effectively applied in drug development and personalized therapy. This review describes several common culture systems for organoids of gynecological malignancies. It discusses the latest technologies related to organoids and their applications in gynecological oncology. Despite limitations, organoids are ideal preclinical models and a promising platform for tumor research.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Obstetrics & Gynecology Hospital of Fudan University, Shanghai Key Lab of Reproduction and Development, Shanghai Key Lab of Female Reproductive Endocrine Related Diseases, 200433 Shanghai, China.
- Obstetrics & Gynecology Hospital of Fudan University, Shanghai Key Lab of Reproduction and Development, Shanghai Key Lab of Female Reproductive Endocrine Related Diseases, 200433 Shanghai, China. Electronic address: qux…
- Obstetrics & Gynecology Hospital of Fudan University, Shanghai Key Lab of Reproduction and Development, Shanghai Key Lab of Female Reproductive Endocrine Related Diseases, 200433 Shanghai, China. Electronic address: hua…
- Obstetrics & Gynecology Hospital of Fudan University, Shanghai Key Lab of Reproduction and Development, Shanghai Key Lab of Female Reproductive Endocrine Related Diseases, 200433 Shanghai, China. Electronic address: qiu…
Zitieren
APA
Ding, Z., Chang, X., Qu, X., Hua, K., & Qiu, J. (2025). Gynecological malignancy organoids: A game changer for personalized medicine. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. https://doi.org/10.1016/j.bbcan.2025.189405
Vancouver
Ding Z, Chang X, Qu X, Hua K, Qiu J. Gynecological malignancy organoids: A game changer for personalized medicine. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 2025. doi:10.1016/j.bbcan.2025.189405
BibTeX
@article{Ding2025,
author = {Ding, Ziyang and Chang, Xingyu and Qu, Xinyu and Hua, Keqin and Qiu, Junjun},
title = {Gynecological malignancy organoids: A game changer for personalized medicine},
journal = {Biochimica et Biophysica Acta (BBA) - Reviews on Cancer},
year = {2025},
doi = {10.1016/j.bbcan.2025.189405}
}
EUVIMED